Cargando…

Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an In Vitro Study

Antibiotic-loaded bone cement is the most widely used approach for the treatment of biofilm-induced septic sequelae in orthopedic surgery. Dalbavancin is a lipoglycopeptide that acts against Gram-positive bacteria and has a long half-life, so we aimed to assess whether it could be a new alternative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Somolinos, Mar, Díaz-Navarro, Marta, Benjumea, Antonio, Tormo, Marta, Matas, José, Vaquero, Javier, Muñoz, Patricia, Sanz-Ruíz, Pablo, Guembe, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598415/ https://www.ncbi.nlm.nih.gov/pubmed/36289958 http://dx.doi.org/10.3390/antibiotics11101300

Ejemplares similares

In Vitro Efficacy of Dalbavancin as a Long-Acting Anti-Biofilm Agent Loaded in Bone Cement
por: Sánchez-Somolinos, Mar, et al.
Publicado: (2023)

Effect of Tranexamic Acid against Staphylococcus spp. and Cutibacterium acnes Associated with Peri-Implant Infection: Results from an In Vitro Study
por: Benjumea, Antonio, et al.
Publicado: (2022)

Tranexamic Acid in Combination With Vancomycin or Gentamicin Has a Synergistic Effect Against Staphylococci
por: Benjumea, Antonio, et al.
Publicado: (2022)

A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing
por: Díaz-Navarro, Marta, et al.
Publicado: (2022)

Correction to: A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing
por: Díaz-Navarro, Marta, et al.
Publicado: (2022)

An In Vitro Study to Assess the Best Strategy for the Chemical Debridement of Periprosthetic Joint Infection
por: Márquez-Gómez, Miguel, et al.
Publicado: (2023)

Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review
por: Buzón-Martín, Luis, et al.
Publicado: (2021)

Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety
por: Ruiz-Sancho, Andrés, et al.
Publicado: (2023)

Corynebacterium striatum Prosthetic Joint Infection Successfully Treated with Long-Term Dalbavancin
por: Söderquist, Bo, et al.
Publicado: (2023)

Ototoxicity associated with extended dalbavancin treatment for a shoulder prosthetic joint infection
por: Lange, Anna, et al.
Publicado: (2023)

Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)

Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections
por: Sivori, Francesca, et al.
Publicado: (2022)

Effect of Dalbavancin on Staphylococcal Biofilms When Administered Alone or in Combination With Biofilm-Detaching Compounds
por: Žiemytė, Miglë, et al.
Publicado: (2020)

Peri‐prosthetic tissue cells show osteogenic capacity to differentiate into the osteoblastic lineage
por: Schoeman, Monique A.E., et al.
Publicado: (2017)

Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections
por: Gallerani, Altea, et al.
Publicado: (2023)

In vitro additive effects of dalbavancin and rifampicin against biofilm of Staphylococcus aureus
por: Jacob, Benjamin, et al.
Publicado: (2021)

Imaging in peri-prosthetic assessment: an orthopaedic perspective
por: Lohmann, Christoph H., et al.
Publicado: (2017)

Revision TKA with a condylar constrained prosthesis using metaphyseal and surface cementation: a minimum 6-year follow-up analysis
por: Sanz-Ruiz, Pablo, et al.
Publicado: (2015)

In vitro study to assess modulation of Candida biofilm by Escherichia coli from vaginal strains
por: Díaz-Navarro, Marta, et al.
Publicado: (2023)

Composite Bone Cements with Enhanced Drug Elution
por: Cherednichenko, Kirill, et al.
Publicado: (2023)

Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin
por: Oliva, Alessandra, et al.
Publicado: (2021)

Determination of the ability of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify high-biofilm-producing strains
por: Rodríguez-Temporal, David, et al.
Publicado: (2023)

Dalbavancin: a novel antimicrobial
por: Chen, A Y, et al.
Publicado: (2007)

Automatic detection and classification of peri-prosthetic femur fracture
por: Alzaid, Asma, et al.
Publicado: (2022)

Acetabular Peri-Prosthetic Fractures—A Narrative Review
por: Beckers, Gautier, et al.
Publicado: (2022)

Effect of Ultrasound Frequency and Treatment Duration on Antibiotic Elution from Polymethylmethacrylate Bone Cement
por: Wendling, Alexander C., et al.
Publicado: (2019)

Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
por: Knafl, D., et al.
Publicado: (2016)

Microhardness of bi-antibiotic-eluting bone cement scaffolds
por: Musib, Mrinal, et al.
Publicado: (2012)

Elution and Biomechanical Properties of Meropenem‐Loaded Bone Cement
por: Wang, Li‐hong, et al.
Publicado: (2021)

Emerging resistance in Staphylococcus epidermidis during dalbavancin exposure: a case report and in vitro analysis of isolates from prosthetic joint infections
por: Al Janabi, Jasmina, et al.
Publicado: (2023)

Non-prosthetic peri-implant fracture of both forearm bones
por: Prieto Meré, Jose Antonio, et al.
Publicado: (2023)

Dalbavancin in clinical practice in Spain: a 2 year retrospective study
por: Morata, Laura, et al.
Publicado: (2022)

267 Dalbavancin for the treatment of Streptococcal Skin Infections
por: Puttagunta, Sailaja, et al.
Publicado: (2014)

Successful Treatment of Diabetic Foot Osteomyelitis with Dalbavancin
por: Loupa, Chariclia V., et al.
Publicado: (2020)

Dalbavancin: novel candidate for COVID-19 treatment
por: Hoffmann, Markus, et al.
Publicado: (2021)

Evaluating the Use of Dalbavancin for Off-Label Indications
por: Taylor, Katherine, et al.
Publicado: (2022)

Global trends of dalbavancin: A bibliometric analysis
por: Monteagudo‐Martínez, Nuria, et al.
Publicado: (2022)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
por: Molinelli, Elisa, et al.
Publicado: (2022)

Dalbavancin for Staphylococcus aureus Bacteremia: Are We There Yet?
por: Mahatanan, Rattanaporn, et al.
Publicado: (2023)

2902. Dalbavancin Use in Bone and Joint Infections
por: Sanikommu, Srivani, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9jetpm7ilc0skdusccdq9l6m1j